| Home | E-Submission | Sitemap | Editorial Office |  
top_img
Radiation Oncology Journal Search > Browse Articles > Search



Long-term toxicities after allogeneic hematopoietic stem cell transplantation with or without total body irradiation: a population-based study in Korea
Jeanny Kwon, Byoung Hyuck Kim
Radiat Oncol J. 2024;42(1):50-62.   Published online 2024 Jan 16     DOI: https://doi.org/10.3857/roj.2023.00871
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    PDFSupplementary Material
Evidence-based clinical recommendations for hypofractionated radiotherapy: exploring efficacy and safety - Part 1. Brain and head and neck
Soo-Yoon Sung, Jin Ho Song, Byoung Hyuck Kim, Yoo-Kang Kwak, Kyung Su Kim, Gyu Sang Yoo, Hwa Kyung Byun, Yeon Joo Kim, Yeon-Sil Kim
Radiat Oncol J. 2024;42(1):17-31.   Published online 2024 Mar 14     DOI: https://doi.org/10.3857/roj.2023.00899
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    
Radiomics in stereotactic body radiotherapy for non-small cell lung cancer: a systematic review and radiomic quality score study
Ben Man Fei Cheung
Radiat Oncol J. 2024;42(1):4-16.   Published online 2024 Feb 21     DOI: https://doi.org/10.3857/roj.2023.00612
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    PDFSupplementary Material
CyberKnife-based stereotactic radiosurgery or fractionated stereotactic radiotherapy in older patients with brain metastases from non-small cell lung cancer
Jeongshim Lee, Hun Jung Kim, Woo Chul Kim
Radiat Oncol J. 2023;41(4):258-266.   Published online 2023 Nov 28     DOI: https://doi.org/10.3857/roj.2023.00563
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    
A comparison of conventional and accelerated hypofractionated radiotherapy in definitive chemoradiation for locally advanced head and neck carcinoma: a retrospective cohort study
Arkaja Tripathy, Sandeep Muzumder, Nirmala Srikantia, Ajay Babu, MG John Sebastian, Avinash H. Udayashankar, Ganesha Dev Vashishta, John Michael Raj
Radiat Oncol J. 2023;41(4):248-257.   Published online 2023 Oct 19     DOI: https://doi.org/10.3857/roj.2023.00248
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    PDFSupplementary Material   Web of Science 1  Crossref 1
Radiotherapy dose de-escalation in patients with high grade non-Hodgkin lymphoma in a real-world clinical practice
Budhi Singh Yadav, Treshita Dey
Radiat Oncol J. 2023;41(4):237-247.   Published online 2023 Sep 25     DOI: https://doi.org/10.3857/roj.2023.00339
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    
Exploring the past, present, and future of postoperative radiotherapy for N2 stage non-small cell lung cancer
Byoung Hyuck Kim, Jae Sik Kim, Hak Jae Kim
Radiat Oncol J. 2023;41(3):144-153.   Published online 2023 Aug 23     DOI: https://doi.org/10.3857/roj.2023.00430
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF       Crossref 1
Radiotherapy combined with immunotherapy could improve the immune infiltration of melanoma in mice and enhance the abscopal effect
Yufeng Zheng, Xue Liu, Na Li, Aimei Zhao, Zhiqiang Sun, Meihua Wang, Judong Luo
Radiat Oncol J. 2023;41(2):129-139.   Published online 2023 Jun 29     DOI: https://doi.org/10.3857/roj.2023.00185
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    PDFSupplementary Material   Crossref 1
Evaluation of the role of inflammatory blood markers in predicting the pathological response after neoadjuvant chemoradiation in patients with locally advanced rectal cancer
Shahram Manoochehry, Hamid Reza Rasouli, Fathollah Ahmadpour, Alireza Keramati
Radiat Oncol J. 2023;41(2):81-88.   Published online 2023 Jun 28     DOI: https://doi.org/10.3857/roj.2023.00115
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    
Research progress and treatment of radiation enteritis and gut microbiota
Huiwen Ren, Qi Wu, Zhiqiang Sun, Mingming Fang, Jun Liu, Judong Luo
Radiat Oncol J. 2023;41(2):61-68.   Published online 2023 Jun 28     DOI: https://doi.org/10.3857/roj.2023.00346
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF       Crossref 1
Peripheral blood lymphocyte changes after stereotactic ablative body radiotherapy to lung or liver metastases in patients with oligometastatic cancers
Sergey Nikolaevich Novikov, Irina Aleksandrovna Baldueva, Anton Yurievich Zozulya, Natalya Viktorovna Emelyanova, Dmitriy Viktorovich Girdyuk, Andrey Ivanovich Arsenyev, Elena Alexandrovna, Elena Ivanovna Tyuryaeva, E. I. Filip Evgenevich Antipov, Mikhail Markovich Girshovich, Sergey Vasilevich Kanayev
Radiat Oncol J. 2023;41(1):23-31.   Published online 2023 Feb 27     DOI: https://doi.org/10.3857/roj.2022.00521
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    PDFSupplementary Material   Web of Science 1  Crossref 3
A practical review of watch-and-wait approach in rectal cancer
Hwa Kyung Byun, Woong Sub Koom
Radiat Oncol J. 2023;41(1):4-11.   Published online 2023 Mar 28     DOI: https://doi.org/10.3857/roj.2023.00038
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF       Web of Science 1  Crossref 2
Stereotactic radiosurgery for limited brain metastasis using three different techniques: helical tomotherapy, volumetric modulated arc therapy, and cone-based LINAC radiosurgery
Bongkot Jia-Mahasap, Chakri Madla, Patumrat Sripan, Imjai Chitapanarux, Ekkasit Tharavichitkul, Somvilai Chakrabandhu, Pitchayaponne Klunklin, Wimrak Onchan
Radiat Oncol J. 2022;40(4):232-241.   Published online 2022 Dec 26     DOI: https://doi.org/10.3857/roj.2022.00136
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    PDFSupplementary Material   Web of Science 1  Crossref 1
Journey to hypofractionation in radiotherapy for breast cancer: critical reviews for recent updates
Nalee Kim, Yong Bae Kim
Radiat Oncol J. 2022;40(4):216-224.   Published online 2022 Dec 26     DOI: https://doi.org/10.3857/roj.2022.00577
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF       Web of Science 6  Crossref 7
A comparison between high dose rate brachytherapy and stereotactic body radiotherapy boost after elective pelvic irradiation for high and very high-risk prostate cancer
Sergey Nikolaevich Novikov, Roman Vladimirovich Novikov, Yurii Olegovich Merezhko, Mariya Yurevna Gotovchikova, Nikolai Dmitrievich Ilin, Yulia Sergeevna Melnik, Sergey Vasilevich Kanaev
Radiat Oncol J. 2022;40(3):200-207.   Published online 2022 Sep 30     DOI: https://doi.org/10.3857/roj.2022.00339
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF       Web of Science 1  Crossref 1
Bone-only oligometastatic prostate cancer: can SABR improve outcomes? A single-center experience
Ángel L. Sánchez-Iglesias, Virginia Morillo-Macías, Ana Santafé-Jiménez, Carlos Ferrer-Albiach
Radiat Oncol J. 2022;40(3):192-199.   Published online 2022 Sep 27     DOI: https://doi.org/10.3857/roj.2022.00101
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF       Web of Science 1  Crossref 1
Craniospinal irradiation for respiratory failure secondary to central nervous system Erdheim-Chester disease
Rahul N. Prasad, Peter J. Kobalka, Haley K. Perlow, Daniel M. Prevedello, Dukagjin M. Blakaj, Raju R. Raval, Joshua D. Palmer
Radiat Oncol J. 2022;40(2):162-168.   Published online 2022 May 20     DOI: https://doi.org/10.3857/roj.2021.01074
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF       Web of Science 1  Crossref 1
Clinical Investigations
Radiobiological analysis of preliminary results of a phase II study of pelvic hypofractionated and accelerated radiotherapy for high-risk prostate cancer patients
Christos Nanos, Vasilios Souftas, Athanasios Zissimopoulos, Michael I. Koukourakis
Radiat Oncol J. 2022;40(2):151-161.   Published online 2022 Jun 20     DOI: https://doi.org/10.3857/roj.2021.01032
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    
Long-term oncological outcomes of hypofractionated versus conventional fractionated whole breast irradiation with simultaneous integrated boost in early-stage breast cancer
Chawalit Lertbutsayanukul, Manida Pitak, Chonnipa Nantavithya
Radiat Oncol J. 2022;40(2):141-150.   Published online 2022 May 20     DOI: https://doi.org/10.3857/roj.2021.00927
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    PDFSupplementary Material   Web of Science 3  Crossref 2
Accelerated hypofractionated breast radiotherapy with simultaneous integrated boost: a feasibility study
Budhi Singh Yadav, Shipra Gupta, Divya Dahiya, Ankita Gupta, Arun Singh Oinam
Radiat Oncol J. 2022;40(2):127-140.   Published online 2022 Jun 20     DOI: https://doi.org/10.3857/roj.2021.01053
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF       Web of Science 1  Crossref 4
Hypofractionated radiotherapy for early stage glottic cancer: efficacy of 3.5 Gy per fraction
Tae Hoon Lee, Joo Ho Lee, Seong Keun Kwon, Eun-Jae Chung, Hong-Gyun Wu
Radiat Oncol J. 2022;40(2):120-126.   Published online 2022 May 17     DOI: https://doi.org/10.3857/roj.2021.01025
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF       Web of Science 2  Crossref 2
Post-radiation neutrophil-to-lymphocyte ratio is a prognostic marker in patients with localized pancreatic adenocarcinoma treated with anti-PD-1 antibody and stereotactic body radiation therapy
Abhinav V. Reddy, Colin S. Hill, Shuchi Sehgal, Lei Zheng, Jin He, Daniel A. Laheru, Ana De Jesus-Acosta, Joseph M. Herman, Jeffrey Meyer, Amol K. Narang
Radiat Oncol J. 2022;40(2):111-119.   Published online 2022 May 20     DOI: https://doi.org/10.3857/roj.2021.01060
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    PDFSupplementary Material   Web of Science 7  Crossref 7
Biology contributions
Immunomodulatory effect of splenectomy in lung cancer mouse xenograft models receiving radiation therapy
Yeeun Kim, Changhoon Choi, Jee Hyun Park, Won-Gyun Ahn, Sung-Won Shin, Shin-Yeong Kim, Jae Myoung Noh
Radiat Oncol J. 2022;40(1):53-65.   Published online 2022 Feb 23     DOI: https://doi.org/10.3857/roj.2021.00885
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF       Web of Science 2  Crossref 2
Clinical Investigations
Long-term outcomes of low-dose radiotherapy in Kasabach-Merritt syndrome
Dowook Kim, Jung Yoon Choi, Kyung Taek Hong, Hyoung Jin Kang, Il Han Kim, Joo Ho Lee
Radiat Oncol J. 2022;40(1):45-52.   Published online 2022 Mar 22     DOI: https://doi.org/10.3857/roj.2021.00983
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF       Crossref 1
PIVKA-II as a surrogate marker for prognosis in patients with localized hepatocellular carcinoma receiving stereotactic body radiotherapy
Ick Joon Cho, Jae-Uk Jeong, Taek-Keun Nam, Young-Eun Joo, Sung-Bum Cho, Yong-Hyub Kim, Ju-Young Song, Mee Sun Yoon, Sung-Ja Ahn, Woong-Ki Chung
Radiat Oncol J. 2022;40(1):20-28.   Published online 2022 Mar 25     DOI: https://doi.org/10.3857/roj.2021.00934
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF       Web of Science 3  Crossref 4
Impact of somatic mutations on clinical and pathologic outcomes in borderline resectable and locally advanced pancreatic cancer treated with neoadjuvant chemotherapy and stereotactic body radiotherapy followed by surgical resection
Abhinav V. Reddy, Colin S. Hill, Shuchi Sehgal, Ding Ding, Amy Hacker-Prietz, Jin He, Lei Zheng, Joseph M. Herman, Jeffrey Meyer, Amol K. Narang
Radiat Oncol J. 2021;39(4):304-314.   Published online 2021 Dec 17     DOI: https://doi.org/10.3857/roj.2021.00815
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    PDFSupplementary Material   Web of Science 7  Crossref 6
Efficacy and safety of sequential neoadjuvant chemotherapy and short-course radiation therapy followed by delayed surgery in locally advanced rectal cancer: a single-arm phase II clinical trial with subgroup analysis between the older and young patients
Alimohammad Bananzadeh, Ali Akbar Hafezi, NamPhong Nguyen, Shapour Omidvari, Ahmad Mosalaei, Niloofar Ahmadloo, Mansour Ansari, Mohammad Mohammadianpanah
Radiat Oncol J. 2021;39(4):270-278.   Published online 2021 Oct 26     DOI: https://doi.org/10.3857/roj.2021.00654
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF       Web of Science 2  Crossref 2
Hyperfractionated radiotherapy for re-irradiation of recurrent esophageal cancer
Kazuya Takeda, Haruo Matsushita, Rei Umezawa, Takaya Yamamoto, Yojiro Ishikawa, Noriyoshi Takahashi, Yu Suzuki, Keiichi Jingu
Radiat Oncol J. 2021;39(4):265-269.   Published online 2021 Sep 3     DOI: https://doi.org/10.3857/roj.2021.00325
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF       Web of Science 4  Crossref 2
Computed tomography-based radiomic model predicts radiological response following stereotactic body radiation therapy in early-stage non-small-cell lung cancer and pulmonary oligo-metastases
Ben Man Fei Cheung, Kin Sang Lau, Victor Ho Fun Lee, To Wai Leung, Feng-Ming Spring Kong, Mai Yee Luk, Kwok Keung Yuen
Radiat Oncol J. 2021;39(4):254-264.   Published online 2021 Oct 26     DOI: https://doi.org/10.3857/roj.2021.00311
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    PDFSupplementary Material   Web of Science 3  Crossref 3
Abscopal effect in the radio and immunotherapy
Alina M. Pevzner, Matvey M. Tsyganov, Marina K. Ibragimova, Nikolai V. Litvyakov
Radiat Oncol J. 2021;39(4):247-253.   Published online 2021 Oct 25     DOI: https://doi.org/10.3857/roj.2021.00115
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF       Web of Science 14  Crossref 14
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | Next
E-Submission
Principles of Transparency and Best Practice
Author's Index
KOSRO
Journal Impact Factor 2.3
SCImago Journal & Country Rank
PubMed Central
PubMed
Scopus
KoreaMed
KoMCI
ScienceCentral
GoogleScholar
Similarity Check
Crossref Cited-by Linking
CrossMark
Funder Registry
Metadata
ORCID
COPE
Elekta Korea
DAWON MEDAX
Editorial Office
Department of Radiation Oncology, Samsung Medical Center,
Proton Therapy Center, B2, 81, Irwon-ro, Gangnam-gu, Seoul 06351, Republic of Korea
Tel : +82-2-3410-3617
E-mail: rojeditor@gmail.com, roj@kosro.or.kr
Copyright © The Korean Society for Radiation Oncology.                      Developed in M2PI
Close layer
prev next